In a PDA mouse model, adult acinar cells have been found to be resistant to transformation by the Kras oncogene or a combination of Kras and loss of tumor suppressors (e.g., Trp53); however, treating caerulein induces pancreatitis and accelerates the development of PDA [9]. The gene discussed is KRAS; the disease is Patent ductus arteriosus.